Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NICE (NICE) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for NICE (NICE) over the last 17 years, with Q3 2025 value amounting to $418.1 million.

  • NICE's Cash & Equivalents fell 3729.85% to $418.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $418.1 million, marking a year-over-year decrease of 3729.85%. This contributed to the annual value of $536.6 million for FY2025, which is 2744.71% down from last year.
  • According to the latest figures from Q3 2025, NICE's Cash & Equivalents is $418.1 million, which was down 3729.85% from $536.6 million recorded in Q2 2025.
  • NICE's Cash & Equivalents' 5-year high stood at $793.1 million during Q1 2024, with a 5-year trough of $343.5 million in Q2 2021.
  • For the 5-year period, NICE's Cash & Equivalents averaged around $523.1 million, with its median value being $481.7 million (2024).
  • As far as peak fluctuations go, NICE's Cash & Equivalents soared by 6856.64% in 2023, and later plummeted by 4079.62% in 2025.
  • NICE's Cash & Equivalents (Quarter) stood at $378.7 million in 2021, then skyrocketed by 39.86% to $529.6 million in 2022, then dropped by 3.36% to $511.8 million in 2023, then decreased by 5.88% to $481.7 million in 2024, then decreased by 13.22% to $418.1 million in 2025.
  • Its Cash & Equivalents stands at $418.1 million for Q3 2025, versus $536.6 million for Q2 2025 and $469.5 million for Q1 2025.